Example: Heart Attack

Search clinical trials for: Hydrocodone

Total 157 results

NCT01922739

Completed

Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets

Conditions: Low Back Pain
NCT01223365

Completed

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Conditions: Chronic Pain
NCT01400139

Completed

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

Conditions: Chronic Nonmalignant and Nonneuropathic Pain
NCT01789970

Completed

Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain

Conditions: Low Back Pain
NCT01452529

Completed

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Conditions: Chronic Low Back Pain
NCT01517295

Completed

Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients

Conditions: Chronic Pain
NCT01115569

Completed

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

Conditions: Chronic Pain
NCT01240863

Completed

Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time

Conditions: Chronic Pain
NCT01596673

Completed

A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users

Conditions: Drug Abuse
NCT01758978

Completed

A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

Conditions: Pain
NCT00802087

Completed

Single Dose Pharmacokinetics of Egalet® Hydrocodone

Conditions: Pain
NCT01769677

Completed

A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

Conditions: Pain
NCT00935311

Completed

Hydrocodone/Acetaminophen for Acute Pain Following Third Molar Tooth Extraction

Conditions: Pain
NCT01319279

Completed

A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment

Conditions: Hepatic Impairment
NCT01319266

Completed

A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment

Conditions: Renal Impairment
NCT01081912

Completed

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Conditions: Back Pain Lower Back Chronic
NCT02542098

Withdrawn

Safety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in Children

Conditions: Pain
NCT02222740

Completed

A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain

Conditions: Osteoarthrosis
NCT00404183

Completed

A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With Osteoarthritis

Conditions: Pain
NCT00402792

Completed

A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following Bunionectomy

Conditions: Pain
NCT00853190

Completed

Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension

Conditions: Healthy
NCT00853294

Completed

Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension

Conditions: Healthy
NCT03137017

Withdrawn

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults

Conditions: Opioid-Related Disorders; Pain, Acute; Pain, Postoperative
NCT03642873

Completed

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate

Conditions: Healthy Subjects
NCT00195728

Completed

Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain

Conditions: Moderate to Severe Chronic, Non-malignant Pain